Asia-Pacific Tracheostomy Products Market – Industry Trends and Forecast to 2030

Asia-Pacific Tracheostomy Products Market Analysis and Size

Lung cancer cases are projected to rise globally due to the increase in smokers who are dependent on tobacco. Lung cancer is the most frequent cancer form that results in fatalities in India, according to the Indian Council of Medical Research or ICMR. This illness is thought to have contributed to 180,000 deaths in 2021. Lung cancer is the second most common cancer type in men and the third most common cancer type in women in Brazil, according to figures from the Brazilian National Cancer Institute. Lung cancer contributed to almost 34,000 fatalities in this nation in 2018. A rise in lung cancer cases is anticipated to support market expansion during the forecast period.

Data Bridge Market Research analyses that the tracheostomy products market which is USD 55051.54 thousand in 2022, is expected to reach USD 93883.90 thousand by 2030, at a CAGR of 6.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Asia-Pacific Tracheostomy Products Market Scope and Segmentation  

Market Definition

A tracheostomy is a surgically created conduit that extends across the front of the neck and through the trachea. The patient can breathe to a tube that is inserted into the hole. By doing so, the nose, mouth and throat are avoided, the air may enter the lung, and the lung secretions can be expelled. In severe circumstances, tracheostomy is permanent. However, if no longer required, the hole is plugged. This procedure may result in a number of consequences, including bleeding, permanent vocal damage, and infections, among others. Patients with neck cancer, neck injuries, chronic lung disorders, long-term ventilation support, and vocal cord paralysis among other conditions are treated with tracheostomies.

Asia-Pacific Tracheostomy Products Market Dynamics

Drivers

• Rise in respiratory illnesses

The rise in respiratory illnesses such asthma, exercise-induced bronchospasm, emphysema, allergic rhinitis, primary dysmenorrhea, pneumonia and lung cancer is the main driver driving the market's expansion. For instance, the COPD prevalence was higher in smokers compared to non-smokers and the majority of the national data revealed that COPD was diagnosed in about 6.0% of the adult population worldwide, according to the Global Initiative for Chronic Obstructive Lung Disease 2021 study. Furthermore, more than 262.0 million people had asthma in 2021, according to the WHO 2022 update. When the natural breathing route is obstructed or restricted, the tracheostomy products offer a breathing passage that aids in breathing. Patients with asthma and other respiratory conditions are strongly advised to take it. In light of this, it is projected that rising respiratory disease incidences will increase demand for tracheostomy products, which will fuel market expansion.

• High prevalence of oral and lung cancer

Patients with head and neck cancers, such as thyroid cancer, oral cancer, and tongue cancer are most frequently treated with tracheostomies. For instance, more than 2.2 million new instances of lung cancer were reported in 2021, according to the World Cancer Research Fund International's 2022 report. Mouth and oral cancers refer to cancers of the lip, oral cavity, hypopharynx, oropharynx, and larynx as a whole. The same source also stated that in 2021, there will be more than 377,700 new instances of malignancies of the lip and oral cavity worldwide. As a result, it is projected that the high prevalence of oral and lung cancer will accelerate market expansion throughout the forecast period.

Opportunities

• Partnerships and collaborations

The market is expanding as a result of partnerships and collaborations between major players, technological developments and rising product approval rates. For instance, in January 2020, Smiths Medical added Portex, a new Polyvinyl Chloride (PVC) tracheostomy tube portfolio, to its line of tracheostomy tubes. The demand for tracheostomy tubes is anticipated to increase as a result of new introductions and an increase in obstructive sleep apnea (OSA) cases, driving the growth during the forecast period.

Restraints/Challenges

• High cost of tonometer devices

High cost of tracheostomy products and the low adoption rate in emerging and underdeveloped countries will obstruct the market's growth rate.

This tracheostomy products market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the tracheostomy products market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Tracheostomy Products Market

The COVID-19 pandemic has significantly increased the number of people needing mechanical ventilation and other respiratory assistance. Long-term mechanical breathing is required for these patients but some of them also need tracheostomies to enable weaning and make better use of hospital resources. However, because of the creation of aerosols and the high danger of nosocomial transmission to medical personnel, the tracheostomy technique is challenging to conduct. Although percutaneous tracheostomy (PCT) is the gold standard of care in many ICUs, it poses a greater risk of aerosol production.

Recent Developments

• In 2022, the U.S. FDA warned patients, family members, and medical professionals about the lack of tracheostomy tubes, including ICU Medical's Bivona tracheostomy tubes. Furthermore, the FDA noted that due to a lack of substitute tubes with comparable performance, the shortage of Bivona tracheostomy tubes is more likely to impact young patients.
• In 2022, In order to improve its ability to treat patients with complex respiratory disorders, particularly those who have tracheostomies, Candlewood Valley Health & Rehabilitation partnered with Respiratory Services, LLC.

Asia-Pacific Tracheostomy Products Market Scope

The tracheostomy products market is segmented on the basis of product type, technique, type, material, age group, usability, end user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Tracheostomy Tubes
• Tracheostomy Catheter
• Tracheostomy Clean
• Care Kits
• Tracheostomy Oxygen Mask
• Collar
• Tracheostomy Dressing
• Tracheostomy Ventilation Accessories
• Cannula 
• Others

 Technique

• Surgical Tracheostomy
• Translaryngeal/Fantoni Tracheostomy
• Percutaneous Dilatational Tracheostomy

 Type

• Closed System 
• Open System

 Material

• Silicone
• Polymer
• Others

Age Group

• Neonatal
• Pediatric
• Adult 
• Geriatric

Usability

• Disposable 
• Reusable

 End User

• Hospita​​​​​​​ls 
• Surgery Centers
• Long Term Assisted Care
• Outpatient Clinic
• Rehabilitation Centers
• Research Laboratories
• Academic Institutes
• Others

 Distribution Channel

• Direct Tender
• Retail Sales

Asia-Pacific Tracheostomy Products Market Regional Analysis/Insights

The tracheostomy products market is analyzed and market size insights and trends are provided by country, product type, technique, type, material, age group, usability, end user and distribution channel as referenced above.

The countries covered in the tracheostomy products market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China is expected to grow with the most promising growth rate in the forecast period of 2023 to 2030 due of expanding tracheostomy knowledge, COPD incidence and the introduction of COVID-19.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

The tracheostomy products market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for tracheostomy products market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the tracheostomy products market. The data is available for historic period 2011-2021.

Competitive Landscape and Tracheostomy Products Market Share Analysis

The tracheostomy products market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to tracheostomy products market.

Some of the major players operating in the tracheostomy products market are:

• Medtronic (Ireland)
• Stening SRL (Argentina)
• Cook (U.S.)
• Bicakcilar Medical (Istanbul)
• TROGE MEDICAL GmbH (Germany)
• Henan Tuoren Medical Device Co., Ltd. (China)
• Medis Medical (UK) Ltd (U.K.)
• Pulmodyne, Inc. (U.S.)
• Fuji Systems (Japan)
• DEAS S.R.L. (Italy)
• Sterimed Group (India)
• ConvaTec Group PLC (U.K.)
• ICU Medical, Inc. (U.S.)
• Andreas Fahl Medizintechnik – Vertrieb GmbH (Germany)
• Boston Medical Products Inc. (U.S.)
• TRACOE medical GmbH (Germany)
• Teleflex Incorporated (U.S.)
• Well Lead Medical Co., Ltd (China) 

SKU-56952